OPKO Health Inc banner

OPKO Health Inc
NASDAQ:OPK

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
NASDAQ:OPK
Watchlist
Price: 1.19 USD Market Closed
Market Cap: $903.3m

Gross Margin

33.9%
Current
Improving
by 1.3%
vs 3-y average of 32.7%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
33.9%
=
Gross Profit
$205.9m
/
Revenue
$606.9m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
33.9%
=
Gross Profit
$205.9m
/
Revenue
$606.9m

Peer Comparison

Country Company Market Cap Gross
Margin
US
OPKO Health Inc
NASDAQ:OPK
903.3m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
391.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
180.2B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.4B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD
Loading...
AU
CSL Ltd
ASX:CSL
68.1B AUD
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
NL
argenx SE
XBRU:ARGX
37.7B EUR
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
37th
Based on 12 729 companies
37th percentile
33.9%
Low
-24 813% — 28.9%
Typical Range
28.9% — 60.5%
High
60.5% — 10 905 714.3%
Distribution Statistics
the United States of America
Min -24 813%
30th Percentile 28.9%
Median 43%
70th Percentile 60.5%
Max 10 905 714.3%

OPKO Health Inc
Glance View

In the bustling world of healthcare and biotechnology, OPKO Health Inc. stands as a unique and dynamic player. Founded by the ambitious mind of Dr. Phillip Frost, the company has woven itself into the fabric of diverse biomedical sectors. OPKO predicates its enterprise on the integration of complementary businesses ranging from diagnostics to pharmaceuticals, creating synergies that are not just theoretical, but markedly operational. At the heart of its operations lies the interplay between new drug discovery and diagnostics development, allowing OPKO to leverage cutting-edge technologies in crafting novel health solutions. By honing in on significant medical unmet needs, they aspire to deliver innovations that address chronic diseases such as diabetes, oncology, and neurological disorders. This strategic weaving together of distinct healthcare sectors manifests in OPKO's sprawling portfolio—from the renowned Rayaldee, which targets secondary hyperparathyroidism, to its advanced diagnostics segments, which include proprietary tests for specific cancers and other conditions. The company's revenue streams can be best visualized as an interlocking lattice of healthcare services and products. It earns through a blend of product sales, licensing, and collaborative agreements with other biotech and pharmaceutical giants. Rayaldee, as a potent testament to their R&D prowess, contributes robustly to their revenue, while the diagnostics division, powered by their substantial investment in technology and infrastructure, brings in consistent sales from various testing services. The company’s BioReference Laboratories, one of the largest full-service diagnostic laboratories in the U.S., also plays a critical role in their financial architecture, offering both routine and esoteric tests. Additionally, OPKO is involved in strategic collaborations and licensing arrangements, enhancing its market footprint and creating channels for revenue infusion through partnerships with industry leaders. Ultimately, OPKO Health Inc.'s narrative is one of leveraging diversified capabilities and strategic partnerships to carve out a formidable presence in the complex landscape of global healthcare.

OPK Intrinsic Value
HIDDEN
Show
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
33.9%
=
Gross Profit
$205.9m
/
Revenue
$606.9m
What is OPKO Health Inc's current Gross Margin?

The current Gross Margin for OPKO Health Inc is 33.9%, which is above its 3-year median of 32.7%.

How has Gross Margin changed over time?

Over the last 3 years, OPKO Health Inc’s Gross Margin has increased from 28.7% to 33.9%. During this period, it reached a low of 25.1% on Sep 30, 2024 and a high of 38% on Sep 30, 2023.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett